The impact of time on the systemic inflammatory response in pneumococcal pneumonia

被引:26
作者
Calbo, E. [1 ]
Alsina, M. [2 ]
Rodriguez-Carballeira, M. [3 ]
Lite, J. [4 ]
Garau, J.
机构
[1] Univ Autonoma Barcelona, Serv Internal Med, Infect Dis Unit, Hosp Mutua Terrassa, Barcelona 08221, Spain
[2] Hosp Mutua Terrassa, Serv Immunol, Barcelona, Spain
[3] Hosp Mutua Terrassa, Serv Internal Med, Barcelona, Spain
[4] Hosp Mutua Terrassa, Microbiol Serv, Barcelona, Spain
关键词
Cytokines; immunology (infection); innate immune response; pneumonia; Streptococcus pneumoniae; NECROSIS-FACTOR-ALPHA; PATHOGENESIS; DISEASE; MECHANISMS; INFECTION; OUTCOMES; IMPAIRS;
D O I
10.1183/09031936.00052709
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aim of our study was to analyse the impact of time from onset of symptoms on the systemic cytokine concentrations in patients with pneumococcal pneumonia. Adults with severe pneumococcal pneumonia were prospectively included. At admission, vital signs, time from onset of pneumonia symptoms and circulating levels of C-reactive protein (CRP), serum amyloid A (SAA), tumour necrosis factor (TNF)-alpha, and interleukin (IL)-1 beta, IL-6, IL-8, IL-10 and IL-1ra were recorded. 32 patients were included; 13 patients had <48 h of evolution and 19 patients had been sick for >48 h. The group with a longer time of evolution presented higher plasmatic levels of TNF-alpha (19.1+/-8.5 versus 35.5+/-26 pg.mL(-1)), fibrinogen (6+/-1.8 versus 9+/-2); CRP (130+/-85 versus 327+/-131) and SAA (678+/-509 versus 984+/-391). Concentrations of TNF-alpha were associated with the presence of bacteraemia, initial blood pressure <90 mmHg and with a lower oxygen saturation at admission. Likewise, TNF-alpha levels were correlated with concentrations of IL-1 beta (r=0.49), IL-6 (r=0.41) and IL-8 (r=0.40). In pneumococcal pneumonia, patients with a longer time of evolution presented with higher levels of pro-inflammatory cytokines and a higher expression of acute phase proteins, suggesting
引用
收藏
页码:614 / 618
页数:5
相关论文
共 50 条
  • [1] Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response
    Bordon, J. M.
    Fernandez-Botran, R.
    Wiemken, T. L.
    Peyrani, P.
    Uriarte, S. M.
    Arnold, F. W.
    Rodriquez-Hernandez, L.
    Rane, M. J.
    Kelley, R. R.
    Binford, L. E.
    Uppatla, S.
    Cavallazzi, R.
    Blasi, F.
    Aliberti, S.
    Restrepo, M. I.
    Fazeli, S.
    Mathur, A.
    Rahmani, M.
    Ayesu, K.
    Ramirez, J.
    INFECTION, 2015, 43 (06) : 729 - 738
  • [2] Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
    Saleh, Malek
    Abdullah, Mohammed R.
    Schulz, Christian
    Kohler, Thomas
    Pribyl, Thomas
    Jensch, Inga
    Hammerschmidt, Sven
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (84):
  • [3] Impact of bacteremia in a cohort of patients with pneumococcal pneumonia
    Palma, Ileana
    Mosquera, Ricardo
    Demier, Carmen
    Vay, Carlos
    Famiglietti, Angela
    Luna, Carlos M.
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2012, 38 (04) : 422 - 430
  • [4] The impact of tacrolimus on the immunopathogenesis of staphylococcal enterotoxin-induced systemic inflammatory response syndrome and pneumonia
    Tilahun, Ashenafi Y.
    Karau, Melissa J.
    Clark, Chad R.
    Patel, Robin
    Rajagopalan, Govindarajan
    MICROBES AND INFECTION, 2012, 14 (06) : 528 - 536
  • [5] Neutrophil Elastase Subverts the Immune Response by Cleaving Toll-Like Receptors and Cytokines in Pneumococcal Pneumonia
    Domon, Hisanori
    Nagai, Kosuke
    Maekawa, Tomoki
    Oda, Masataka
    Yonezawa, Daisuke
    Takeda, Wataru
    Hiyoshi, Takumi
    Tamura, Hikaru
    Yamaguchi, Masaya
    Kawabata, Shigetada
    Terao, Yutaka
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [6] Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia
    Padrones, S.
    Garcia-Vidal, C.
    Fernandez-Serrano, S.
    Fernandez, A.
    Masuet, C.
    Carratala, J.
    Coromines, M.
    Ardanuy, C.
    Gudiol, F.
    Manresa, F.
    Dorca, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (10) : 1243 - 1251
  • [7] Contribution of Puma to Inflammatory Resolution During Early Pneumococcal Pneumonia
    Kennedy Ii, Daniel E.
    Mody, Perceus
    Gout, Jean-Francois
    Tan, Wei
    Seo, Keun Seok
    Olivier, Alicia K.
    Rosch, Jason W.
    Thornton, Justin A.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [8] Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia
    Carreno, David
    Wanford, Joseph J.
    Jasiunaite, Zydrune
    Hames, Ryan G.
    Chung, Wen Y.
    Dennison, Ashley R.
    Straatman, Kornelis
    Martinez-Pomares, Luisa
    Pareek, Manish
    Orihuela, Carlos J.
    Restrepo, Marcos, I
    Lim, Wei Shen
    Andrew, Peter W.
    Moxon, E. Richard
    Oggioni, Marco R.
    EBIOMEDICINE, 2021, 72
  • [9] Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England
    Saxena, Sonia
    Atchison, Christina
    Cecil, Elizabeth
    Sharland, Mike
    Koshy, Elizabeth
    Bottle, Alex
    JOURNAL OF INFECTION, 2015, 71 (04) : 428 - 436
  • [10] Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease
    Bradshaw, Jessica L.
    Caballero, Armando R.
    Bierdeman, Michael A.
    Adams, Kristen V.
    Pipkins, Haley R.
    Tang, Aihua
    O'Callaghan, Richard J.
    McDaniel, Larry S.
    MSPHERE, 2018, 3 (03):